Invicta Diagnostic Limited (NSE:INVICTA)

Market Cap	829.75M
Revenue (ttm)	301.81M +89.8%
Net Income	48.92M
EPS	5.81
Shares Out	12.57M
PE Ratio	11.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	169,600
Average Volume	36,400
Open	68.00
Previous Close	69.05
Day's Range	68.00 - 69.05
52-Week Range	60.20 - 105.00
Beta	n/a
RSI	42.70
Earnings Date	n/a

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo...

• Industry: Medical Laboratories
• Founded: 2016
• Employees: 113
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INVICTA

Financial Performance

In fiscal year 2025, Invicta Diagnostic's revenue was 301.81 million, an increase of 89.84% compared to the previous year's 158.98 million. Earnings were 48.92 million, an increase of 30.04%.